Dr. Gaurav Marwaha
Claim this profileRush University Medical Center
Studies Lung Cancer
Studies Small Cell Lung Cancer
6 reported clinical trials
19 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Small Cell Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Gaurav Marwaha is currently running
Chemoradiation + Durvalumab
for Lung Cancer
Elderly (age 70 years or older) or \>18 years old AND poor risk (ECOG 2) newly diagnosed stage IIIA-C (AJCC 8th edition) inoperable non-small cell lung cancer (NSCLC) patients are eligible to participate in this phase II open label study of concurrent, split course chemoradiation followed by Durvalumab (MEDI4736).
Recruiting1 award Phase 214 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
More about Gaurav Marwaha
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Gaurav Marwaha has experience with
- Durvalumab
- Docetaxel
- Gemcitabine
- Erlotinib Hydrochloride
- Local Consolidation Therapy
- Pemetrexed Disodium
Breakdown of trials Gaurav Marwaha has run
Lung Cancer
Small Cell Lung Cancer
Small Cell Carcinoma
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gaurav Marwaha specialize in?
Gaurav Marwaha focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Gaurav Marwaha currently recruiting for clinical trials?
Yes, Gaurav Marwaha is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Gaurav Marwaha has studied deeply?
Yes, Gaurav Marwaha has studied treatments such as Durvalumab, Docetaxel, Gemcitabine.
What is the best way to schedule an appointment with Gaurav Marwaha?
Apply for one of the trials that Gaurav Marwaha is conducting.
What is the office address of Gaurav Marwaha?
The office of Gaurav Marwaha is located at: Rush University Medical Center, Chicago, Illinois 60612 United States. This is the address for their practice at the Rush University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.